Jan B. Egan
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
-
- Vitamin D Research Studies
- Lymphoma Diagnosis and Treatment
Papers in
-
- Protein Degradation and Inhibitors 6
-
- Lymphoma Diagnosis and Treatment 4
- Vitamin D Research Studies 4
- Co-authors
- A. Keith Stewart (8 shared papers)Esteban Braggio (12 shared papers)Rafaël Fonseca (10 shared papers)P. Leif Bergsagel (3 shared papers)John D. Carpten (7 shared papers)Jonathan J. Keats (2 shared papers)Scott Van Wier (5 shared papers)Victoria M. Garbitt (3 shared papers)
- Journals
- Blood (6 papers)Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)The Journal of Steroid Biochemistry and Molecular Biology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanyMalaysia
In The Last Decade
Jan B. Egan
33 papers receiving 1.6k citations
Jan B. Egan's Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 674
- Pathology and Forensic Medicine 388
- Genetics 186
- Cancer Research 231
- Oncology 380
Countries citing papers authored by Jan B. Egan
This map shows the geographic impact of Jan B. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan B. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan B. Egan more than expected).
Fields of papers citing papers by Jan B. Egan
This network shows the impact of papers produced by Jan B. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan B. Egan. The network helps show where Jan B. Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan B. Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clonal competition with alternating dominance in multiple myeloma Hit paper breakdown → | 2012 | 457 |
| 2 | 2012 | 286 | |
| 3 | 2015 | 152 | |
| 4 | 2010 | 137 | |
| 5 | 2013 | 123 | |
| 6 | 2009 | 54 | |
| 7 | 2010 | 42 | |
| 8 | 2013 | 40 | |
| 9 | 2015 | 36 | |
| 10 | 2017 | 36 | |
| 11 | 2010 | 33 | |
| 12 | 2021 | 32 | |
| 13 | 2019 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2014 | 17 | |
| 16 | 2014 | 15 | |
| 17 | 2018 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2017 | 9 | |
| 20 | Developing a FHIR-based Framework for Phenome Wide Association Studies: A Case Study with A Pan-Cancer Cohort. | 2020 | 9 |
About Jan B. Egan
Jan B. Egan is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Cancer Research, Hematology and Genetics, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Vitamin D Research Studies (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Vitamin C and Antioxidants Research (2 papers). The work is most often cited by research in Hematology (674 citations), Pathology and Forensic Medicine (388 citations), Genetics (186 citations), Cancer Research (231 citations) and Oncology (380 citations). Jan B. Egan has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include A. Keith Stewart, Esteban Braggio, Rafaël Fonseca, P. Leif Bergsagel, John D. Carpten, Jonathan J. Keats, Scott Van Wier, Victoria M. Garbitt, Marta Chesi and Yan W. Asmann. Their work appears in journals such as Blood, Cancer Research, Journal of Clinical Oncology, The Journal of Steroid Biochemistry and Molecular Biology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.